ACM Research 10-Q: Q3 Revenue $367.7M but Net Income Collapses to $1.5M on Investment Losses
ACMR sits 57% above its 52-week low of $28.46.
Summary
ACM Research's Q3 10-Q confirms $367.7M revenue but shows net income attributable to the parent collapsing to $1.5M on $39.1M of unrealized investment losses, alongside negative operating cash flow of $106.3M for the nine months.
Key Events · Earnings and Guidance · ACMR
-
Q3 Revenue $367.7M, Up 36.6%
Revenue rose to $367.687M from $269.160M a year earlier, with ECP/furnace up 82.9% to $109.5M and advanced packaging/services up 71.2% to $47.5M.
-
Net Income Falls to $1.5M
Net income attributable to ACM Research was $1.544M ($0.02 per share) versus $35.889M ($0.56) a year ago, after a $39.133M unrealized loss on short-term investments and a $7.140M equity-method loss.
-
Operating Income Improves to $55.5M
Income from operations rose to $55.527M from $28.923M on a 41.5% gross margin, down 59 bps year over year on product mix, FX and higher inventory provisions.
-
Cash Burn: -$106.3M Operating, -$223.5M FCF
Nine-month operating cash flow was -$106.339M and free cash flow -$223.522M as inventories grew to $851.2M and receivables to $704.7M; cash plus time deposits totaled $1.28B.
Analysis · ACMR · Technology
The headline revenue number was already out on November 5, but the full 10-Q shows how thin the bottom line really was: a $39.1M unrealized loss on Shanghai-listed securities and a $7.1M equity-method loss cut net income attributable to ACM Research to $1.544M, or $0.02 per share, from $35.9M a year ago. Operating income actually improved to $55.5M on a 41.5% gross margin, so the core tool business is fine — the damage is mark-to-market on the investment portfolio and FX. The bigger structural story is cash: nine-month operating cash flow was -$106.3M and free cash flow -$223.5M as inventories and receivables ballooned, which is why the company is leaning on its banks and on the newly approved ACM Shanghai H-share listing in Hong Kong to fund growth.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 35.1% of the 2636 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACMR was trading at $44.61 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $28.46 to $127.19. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.